Heart attack patients: could a diabetes pill shield your kidneys?
NCT ID NCT06491953
First seen Oct 01, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This study looks at whether a type of diabetes medicine called SGLT2 inhibitors can prevent kidney injury caused by the dye used during heart procedures like angioplasty. About 3,600 adults having heart treatment will be studied. The goal is to see if these drugs, which are already known to help the heart and kidneys long-term, can also protect kidneys right after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, China
Conditions
Explore the condition pages connected to this study.